新聞
新聞
- HAGENS BERMAN BIIB ALERT: Investors in Biogen Inc. (BIIB) With Significant Losses Have Opportunity to Lead Securities Class Action
09.02.2022 / 02:11 - GlobeNewswire - Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments
08.02.2022 / 14:00 - GlobeNewswire - BioCryst Appoints Machelle Sanders to Board of Directors
08.02.2022 / 13:00 - GlobeNewswire - Vir Biotechnology Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global
08.02.2022 / 12:00 - GlobeNewswire - Block & Leviton LLP Has Filed a Lawsuit Against Biogen, Inc. for Securities Law Violations
08.02.2022 / 00:04 - GlobeNewswire - Biogen and Xbrane Announce Commercialization and License Agreement for Proposed Biosimilar Referencing CIMZIA® (Certolizumab pegol) with the Potential to Treat Rheumatoid Arthritis
07.02.2022 / 22:05 - GlobeNewswire - Biogen Q4 revenue drops 4% YoY to land at $2.73B
03.02.2022 / 13:07 - TeleTrader - Alfred W. Sandrock, Jr., M.D., Ph.D. Appointed to Voyager Therapeutics’ Board of Directors and Newly Formed Executive Committee
03.02.2022 / 13:00 - GlobeNewswire - Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody
01.02.2022 / 13:30 - GlobeNewswire - Biogen Announces Nancy Leaming and Brian Posner to Retire from Board of Directors
31.01.2022 / 13:30 - GlobeNewswire